Quest Diagnostics Incorporated (DGX) Shares are Up 2.88%

Quest Diagnostics Incorporated (DGX) : Traders are bullish on Quest Diagnostics Incorporated (DGX) as it has outperformed the S&P 500 by a wide margin of 0.07% in the past 4 weeks. The bullishness in the stock continues even in the near-term as the stock has returned an impressive 2.33%, relative to the S&P 500. The stock has risen by 2.88% in the past week indicating that the buyers are active at lower levels, but the stock is down -1.96% in the past 4 weeks.

The stock has recorded a 20-day Moving Average of 0.16% and the 50-Day Moving Average is 0.96%.The 200 Day SMA reached 12.14% Quest Diagnostics Inc. is up 10.47% in the last 3-month period. Year-to-Date the stock performance stands at 18.92%.


Quest Diagnostics Incorporated (DGX) : The highest short term price target forecast on Quest Diagnostics Incorporated (DGX) is $90 and the lowest target price is $70. A total of 10 equity analysts are currently covering the company. The average price of all the analysts is $80.1 with a standard deviation of $6.59.

Company shares have received an average consensus rating of Hold for the current week Quest Diagnostics Incorporated (NYSE:DGX): The stock opened at $82.93 and touched an intraday high of $83.37 on Friday. During the day, the stock corrected to an intraday low of $82.39, however, the bulls stepped in and pushed the price higher to close in the green at $83.25 with a gain of 0.24% for the day. The total traded volume for the day was 1,142,268. The stock had closed at $83.25 in the previous trading session.

Quest Diagnostics Incorporated is a provider of diagnostic testing information services. The Company consists of two businesses: Diagnostic Information Services and Diagnostic Solutions. Diagnostic Information Services business, consists of two parts, develops and delivers diagnostic testing, information and services to patients, physicians, health plans, hospitals, accountable care organizations (ACOs), integrated delivery networks (IDNs), other commercial laboratories, patients and other customers. Diagnostics Information Services business also provides diagnostic information services, which includes providing clinical testing services, such as routine testing, gene-based and esoteric testing, anatomic pathology services and drugs-of-abuse testing. Diagnostic Solutions includes the Companys other businesses, including central laboratory testing for pharmaceutical and medical device clinical trials, risk assessment services, diagnostic products and healthcare information technology.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.